| Quest Physical Therapy, Llc | |
|
5704 E Lake Sammamish Pkwy Se, Suite 101, Issaquah, WA 98029-8941 | |
| (425) 270-3323 | |
| (425) 270-3326 |
| Full Name | Quest Physical Therapy, Llc |
|---|---|
| Type | Facility |
| Speciality | Physical Therapist |
| Location | 5704 E Lake Sammamish Pkwy Se, Issaquah, Washington |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053624791 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | (* (Not Available)) | Primary |
| Provider Name | Jeffrey G Mitsch |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1225096753 PECOS PAC ID: 9335103415 Enrollment ID: I20041118000107 |
News Archive
For microbiology culture media specialist Lab M, Medica 2013 will see the international debut of µPREP™ - a brand new cost-effective line of bagged, sterile dehydrated culture media that is designed for fast, efficient and convenient reconstitution.
Arena Pharmaceuticals, Inc. reported today data from the pivotal BLOSSOM (Behavioral modification and LOrcaserin Second Study for Obesity Management) Phase 3 trial that demonstrate improvements in patients' body composition, cardiovascular risk factors and quality of life. These findings add to the previously announced top-line BLOSSOM data that showed highly significant weight loss with lorcaserin over one year of treatment in 4,008 patients.
The April issue of the WHO Bulletin features an editorial on the WHO research agenda for influenza; a public health round-up; an article on influenza in Ghana; a research paper on population-based burden of influenza-associated hospitalization in rural western Kenya; and a policy paper on the integration of pneumonia prevention and treatment interventions with immunization services in resource-poor countries.
In a new study published on the preprint server medRxiv, researchers from Laval University and McGill University in Canada reviewed evidence from 18 relevant studies on a possible interaction between influenza vaccines on non-influenza respiratory disease (NIRD).
Treatment to reduce recurrence of hepatitis B appears to improve liver transplant outcomes for some patients, according to a Mayo Clinic study presented at the American Transplant Congress under way May 1-5 in San Diego.
› Verified 2 days ago
| Provider Name | Anthony A Yengo |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1699959247 PECOS PAC ID: 5092895540 Enrollment ID: I20080109000527 |
News Archive
For microbiology culture media specialist Lab M, Medica 2013 will see the international debut of µPREP™ - a brand new cost-effective line of bagged, sterile dehydrated culture media that is designed for fast, efficient and convenient reconstitution.
Arena Pharmaceuticals, Inc. reported today data from the pivotal BLOSSOM (Behavioral modification and LOrcaserin Second Study for Obesity Management) Phase 3 trial that demonstrate improvements in patients' body composition, cardiovascular risk factors and quality of life. These findings add to the previously announced top-line BLOSSOM data that showed highly significant weight loss with lorcaserin over one year of treatment in 4,008 patients.
The April issue of the WHO Bulletin features an editorial on the WHO research agenda for influenza; a public health round-up; an article on influenza in Ghana; a research paper on population-based burden of influenza-associated hospitalization in rural western Kenya; and a policy paper on the integration of pneumonia prevention and treatment interventions with immunization services in resource-poor countries.
In a new study published on the preprint server medRxiv, researchers from Laval University and McGill University in Canada reviewed evidence from 18 relevant studies on a possible interaction between influenza vaccines on non-influenza respiratory disease (NIRD).
Treatment to reduce recurrence of hepatitis B appears to improve liver transplant outcomes for some patients, according to a Mayo Clinic study presented at the American Transplant Congress under way May 1-5 in San Diego.
› Verified 2 days ago
| Provider Name | Stephanie A Boutry |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1922259688 PECOS PAC ID: 6901964071 Enrollment ID: I20081017000360 |
News Archive
For microbiology culture media specialist Lab M, Medica 2013 will see the international debut of µPREP™ - a brand new cost-effective line of bagged, sterile dehydrated culture media that is designed for fast, efficient and convenient reconstitution.
Arena Pharmaceuticals, Inc. reported today data from the pivotal BLOSSOM (Behavioral modification and LOrcaserin Second Study for Obesity Management) Phase 3 trial that demonstrate improvements in patients' body composition, cardiovascular risk factors and quality of life. These findings add to the previously announced top-line BLOSSOM data that showed highly significant weight loss with lorcaserin over one year of treatment in 4,008 patients.
The April issue of the WHO Bulletin features an editorial on the WHO research agenda for influenza; a public health round-up; an article on influenza in Ghana; a research paper on population-based burden of influenza-associated hospitalization in rural western Kenya; and a policy paper on the integration of pneumonia prevention and treatment interventions with immunization services in resource-poor countries.
In a new study published on the preprint server medRxiv, researchers from Laval University and McGill University in Canada reviewed evidence from 18 relevant studies on a possible interaction between influenza vaccines on non-influenza respiratory disease (NIRD).
Treatment to reduce recurrence of hepatitis B appears to improve liver transplant outcomes for some patients, according to a Mayo Clinic study presented at the American Transplant Congress under way May 1-5 in San Diego.
› Verified 2 days ago
| Provider Name | Erika L Johnson |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1295989689 PECOS PAC ID: 2466513460 Enrollment ID: I20081209000764 |
News Archive
For microbiology culture media specialist Lab M, Medica 2013 will see the international debut of µPREP™ - a brand new cost-effective line of bagged, sterile dehydrated culture media that is designed for fast, efficient and convenient reconstitution.
Arena Pharmaceuticals, Inc. reported today data from the pivotal BLOSSOM (Behavioral modification and LOrcaserin Second Study for Obesity Management) Phase 3 trial that demonstrate improvements in patients' body composition, cardiovascular risk factors and quality of life. These findings add to the previously announced top-line BLOSSOM data that showed highly significant weight loss with lorcaserin over one year of treatment in 4,008 patients.
The April issue of the WHO Bulletin features an editorial on the WHO research agenda for influenza; a public health round-up; an article on influenza in Ghana; a research paper on population-based burden of influenza-associated hospitalization in rural western Kenya; and a policy paper on the integration of pneumonia prevention and treatment interventions with immunization services in resource-poor countries.
In a new study published on the preprint server medRxiv, researchers from Laval University and McGill University in Canada reviewed evidence from 18 relevant studies on a possible interaction between influenza vaccines on non-influenza respiratory disease (NIRD).
Treatment to reduce recurrence of hepatitis B appears to improve liver transplant outcomes for some patients, according to a Mayo Clinic study presented at the American Transplant Congress under way May 1-5 in San Diego.
› Verified 2 days ago
| Provider Name | Ethan J Jordt |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1184026023 PECOS PAC ID: 1254655756 Enrollment ID: I20150109000756 |
News Archive
For microbiology culture media specialist Lab M, Medica 2013 will see the international debut of µPREP™ - a brand new cost-effective line of bagged, sterile dehydrated culture media that is designed for fast, efficient and convenient reconstitution.
Arena Pharmaceuticals, Inc. reported today data from the pivotal BLOSSOM (Behavioral modification and LOrcaserin Second Study for Obesity Management) Phase 3 trial that demonstrate improvements in patients' body composition, cardiovascular risk factors and quality of life. These findings add to the previously announced top-line BLOSSOM data that showed highly significant weight loss with lorcaserin over one year of treatment in 4,008 patients.
The April issue of the WHO Bulletin features an editorial on the WHO research agenda for influenza; a public health round-up; an article on influenza in Ghana; a research paper on population-based burden of influenza-associated hospitalization in rural western Kenya; and a policy paper on the integration of pneumonia prevention and treatment interventions with immunization services in resource-poor countries.
In a new study published on the preprint server medRxiv, researchers from Laval University and McGill University in Canada reviewed evidence from 18 relevant studies on a possible interaction between influenza vaccines on non-influenza respiratory disease (NIRD).
Treatment to reduce recurrence of hepatitis B appears to improve liver transplant outcomes for some patients, according to a Mayo Clinic study presented at the American Transplant Congress under way May 1-5 in San Diego.
› Verified 2 days ago
| Provider Name | Catherine Rodriguez |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1891161816 PECOS PAC ID: 3577870518 Enrollment ID: I20150923001781 |
News Archive
For microbiology culture media specialist Lab M, Medica 2013 will see the international debut of µPREP™ - a brand new cost-effective line of bagged, sterile dehydrated culture media that is designed for fast, efficient and convenient reconstitution.
Arena Pharmaceuticals, Inc. reported today data from the pivotal BLOSSOM (Behavioral modification and LOrcaserin Second Study for Obesity Management) Phase 3 trial that demonstrate improvements in patients' body composition, cardiovascular risk factors and quality of life. These findings add to the previously announced top-line BLOSSOM data that showed highly significant weight loss with lorcaserin over one year of treatment in 4,008 patients.
The April issue of the WHO Bulletin features an editorial on the WHO research agenda for influenza; a public health round-up; an article on influenza in Ghana; a research paper on population-based burden of influenza-associated hospitalization in rural western Kenya; and a policy paper on the integration of pneumonia prevention and treatment interventions with immunization services in resource-poor countries.
In a new study published on the preprint server medRxiv, researchers from Laval University and McGill University in Canada reviewed evidence from 18 relevant studies on a possible interaction between influenza vaccines on non-influenza respiratory disease (NIRD).
Treatment to reduce recurrence of hepatitis B appears to improve liver transplant outcomes for some patients, according to a Mayo Clinic study presented at the American Transplant Congress under way May 1-5 in San Diego.
› Verified 2 days ago
| Provider Name | Katie Hertzberg |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1548625981 PECOS PAC ID: 2365746161 Enrollment ID: I20160225002071 |
News Archive
For microbiology culture media specialist Lab M, Medica 2013 will see the international debut of µPREP™ - a brand new cost-effective line of bagged, sterile dehydrated culture media that is designed for fast, efficient and convenient reconstitution.
Arena Pharmaceuticals, Inc. reported today data from the pivotal BLOSSOM (Behavioral modification and LOrcaserin Second Study for Obesity Management) Phase 3 trial that demonstrate improvements in patients' body composition, cardiovascular risk factors and quality of life. These findings add to the previously announced top-line BLOSSOM data that showed highly significant weight loss with lorcaserin over one year of treatment in 4,008 patients.
The April issue of the WHO Bulletin features an editorial on the WHO research agenda for influenza; a public health round-up; an article on influenza in Ghana; a research paper on population-based burden of influenza-associated hospitalization in rural western Kenya; and a policy paper on the integration of pneumonia prevention and treatment interventions with immunization services in resource-poor countries.
In a new study published on the preprint server medRxiv, researchers from Laval University and McGill University in Canada reviewed evidence from 18 relevant studies on a possible interaction between influenza vaccines on non-influenza respiratory disease (NIRD).
Treatment to reduce recurrence of hepatitis B appears to improve liver transplant outcomes for some patients, according to a Mayo Clinic study presented at the American Transplant Congress under way May 1-5 in San Diego.
› Verified 2 days ago
| Provider Name | Joseph Cheng Borin |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1841659554 PECOS PAC ID: 6002114618 Enrollment ID: I20160415000341 |
News Archive
For microbiology culture media specialist Lab M, Medica 2013 will see the international debut of µPREP™ - a brand new cost-effective line of bagged, sterile dehydrated culture media that is designed for fast, efficient and convenient reconstitution.
Arena Pharmaceuticals, Inc. reported today data from the pivotal BLOSSOM (Behavioral modification and LOrcaserin Second Study for Obesity Management) Phase 3 trial that demonstrate improvements in patients' body composition, cardiovascular risk factors and quality of life. These findings add to the previously announced top-line BLOSSOM data that showed highly significant weight loss with lorcaserin over one year of treatment in 4,008 patients.
The April issue of the WHO Bulletin features an editorial on the WHO research agenda for influenza; a public health round-up; an article on influenza in Ghana; a research paper on population-based burden of influenza-associated hospitalization in rural western Kenya; and a policy paper on the integration of pneumonia prevention and treatment interventions with immunization services in resource-poor countries.
In a new study published on the preprint server medRxiv, researchers from Laval University and McGill University in Canada reviewed evidence from 18 relevant studies on a possible interaction between influenza vaccines on non-influenza respiratory disease (NIRD).
Treatment to reduce recurrence of hepatitis B appears to improve liver transplant outcomes for some patients, according to a Mayo Clinic study presented at the American Transplant Congress under way May 1-5 in San Diego.
› Verified 2 days ago
| Provider Name | Olivia Marincov |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1174160568 PECOS PAC ID: 6507291101 Enrollment ID: I20200108001186 |
News Archive
For microbiology culture media specialist Lab M, Medica 2013 will see the international debut of µPREP™ - a brand new cost-effective line of bagged, sterile dehydrated culture media that is designed for fast, efficient and convenient reconstitution.
Arena Pharmaceuticals, Inc. reported today data from the pivotal BLOSSOM (Behavioral modification and LOrcaserin Second Study for Obesity Management) Phase 3 trial that demonstrate improvements in patients' body composition, cardiovascular risk factors and quality of life. These findings add to the previously announced top-line BLOSSOM data that showed highly significant weight loss with lorcaserin over one year of treatment in 4,008 patients.
The April issue of the WHO Bulletin features an editorial on the WHO research agenda for influenza; a public health round-up; an article on influenza in Ghana; a research paper on population-based burden of influenza-associated hospitalization in rural western Kenya; and a policy paper on the integration of pneumonia prevention and treatment interventions with immunization services in resource-poor countries.
In a new study published on the preprint server medRxiv, researchers from Laval University and McGill University in Canada reviewed evidence from 18 relevant studies on a possible interaction between influenza vaccines on non-influenza respiratory disease (NIRD).
Treatment to reduce recurrence of hepatitis B appears to improve liver transplant outcomes for some patients, according to a Mayo Clinic study presented at the American Transplant Congress under way May 1-5 in San Diego.
› Verified 2 days ago
| Provider Name | Dylan B Woodward |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1316532369 PECOS PAC ID: 9830598002 Enrollment ID: I20210520003054 |
News Archive
For microbiology culture media specialist Lab M, Medica 2013 will see the international debut of µPREP™ - a brand new cost-effective line of bagged, sterile dehydrated culture media that is designed for fast, efficient and convenient reconstitution.
Arena Pharmaceuticals, Inc. reported today data from the pivotal BLOSSOM (Behavioral modification and LOrcaserin Second Study for Obesity Management) Phase 3 trial that demonstrate improvements in patients' body composition, cardiovascular risk factors and quality of life. These findings add to the previously announced top-line BLOSSOM data that showed highly significant weight loss with lorcaserin over one year of treatment in 4,008 patients.
The April issue of the WHO Bulletin features an editorial on the WHO research agenda for influenza; a public health round-up; an article on influenza in Ghana; a research paper on population-based burden of influenza-associated hospitalization in rural western Kenya; and a policy paper on the integration of pneumonia prevention and treatment interventions with immunization services in resource-poor countries.
In a new study published on the preprint server medRxiv, researchers from Laval University and McGill University in Canada reviewed evidence from 18 relevant studies on a possible interaction between influenza vaccines on non-influenza respiratory disease (NIRD).
Treatment to reduce recurrence of hepatitis B appears to improve liver transplant outcomes for some patients, according to a Mayo Clinic study presented at the American Transplant Congress under way May 1-5 in San Diego.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Quest Physical Therapy, Llc 5704 E Lake Sammamish Pkwy Se, Suite 101, Issaquah, WA 98029-8941 Ph: (425) 270-3323 | Quest Physical Therapy, Llc 5704 E Lake Sammamish Pkwy Se, Suite 101, Issaquah, WA 98029-8941 Ph: (425) 270-3323 |
News Archive
For microbiology culture media specialist Lab M, Medica 2013 will see the international debut of µPREP™ - a brand new cost-effective line of bagged, sterile dehydrated culture media that is designed for fast, efficient and convenient reconstitution.
Arena Pharmaceuticals, Inc. reported today data from the pivotal BLOSSOM (Behavioral modification and LOrcaserin Second Study for Obesity Management) Phase 3 trial that demonstrate improvements in patients' body composition, cardiovascular risk factors and quality of life. These findings add to the previously announced top-line BLOSSOM data that showed highly significant weight loss with lorcaserin over one year of treatment in 4,008 patients.
The April issue of the WHO Bulletin features an editorial on the WHO research agenda for influenza; a public health round-up; an article on influenza in Ghana; a research paper on population-based burden of influenza-associated hospitalization in rural western Kenya; and a policy paper on the integration of pneumonia prevention and treatment interventions with immunization services in resource-poor countries.
In a new study published on the preprint server medRxiv, researchers from Laval University and McGill University in Canada reviewed evidence from 18 relevant studies on a possible interaction between influenza vaccines on non-influenza respiratory disease (NIRD).
Treatment to reduce recurrence of hepatitis B appears to improve liver transplant outcomes for some patients, according to a Mayo Clinic study presented at the American Transplant Congress under way May 1-5 in San Diego.
› Verified 2 days ago
Beth Simon Crabtree, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 710 Nw Juniper St, Ste 104, Issaquah, WA 98027 Phone: 425-392-7989 Fax: 425-391-2554 | |
Kyle Brandon Mark, PT, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 510 8th Ave Ne Suite 340, Issaquah, WA 98029 Phone: 425-313-3055 Fax: 425-313-3051 | |
Nattika Detskultorn, Physical Therapist Medicare: Medicare Enrolled Practice Location: 1301 4th Ave Nw Ste 100, Issaquah, WA 98027 Phone: 425-392-7989 | |
Jhansi Juluri, Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 405 Nw Gilman Blvd Ste 200, Issaquah, WA 98027 Phone: 425-392-6804 Fax: 425-392-6805 | |
Rebekah D Ley, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 6520 226th Pl Se, Suite 205, Issaquah, WA 98027 Phone: 425-392-8611 Fax: 425-392-9012 | |
Kevin Michael Traupmann, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 510 8th Ave Ne Ste 340, Issaquah, WA 98029 Phone: 425-313-3055 Fax: 425-313-3051 | |
Ms. Cathy A. Olson, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 600 Nw Gilman Blvd, Suite A, Issaquah, WA 98027 Phone: 425-313-3055 Fax: 425-313-3051 |